Molecular genetics to genomic medicine practice: at the heart of value-based delivery of healthcare

Affiliations

¹ Genomic Medicine Institute, Lerner Research Institute, Taussig Cancer Institute and Stanley Shalom Zielony Institute of Nursing Research, Cleveland Clinic Cleveland, OH, 44195 ; Department of Genetics and Genome Sciences, CASE Comprehensive Cancer Center, Case Western Reserve University School of Medicine Cleveland, OH, 44116.

Charis Eng. Mol Genet Genomic Med. 2013 May.

. 2013 May;1(1):4-6.

doi: 10.1002/mgg3.8.

¹ Genomic Medicine Institute, Lerner Research Institute, Taussig Cancer Institute and Stanley Shalom Zielony Institute of Nursing Research, Cleveland Clinic Cleveland, OH, 44195 ; Department of Genetics and Genome Sciences, CASE Comprehensive Cancer Center, Case Western Reserve University School of Medicine Cleveland, OH, 44116.

No abstract available

References

1. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med. 1998;338:1481–1487. - PubMed
1. Doërr M, Eng C. Personalised care and the genome. BMJ. 2012;344:e3174. - PubMed
1. Elshaug AG, McWilliams JM, Landon BE. The value of low-value lists. JAMA. 2013;309:775–776. - PubMed
1. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) N. Engl. J. Med. 2005;352:1851–1860. - PubMed
1. Heald B, Plesec T, Liu X, Pai R, Patil D, Moline J, et al. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing Lynch syndrome in a large academic medical center. J. Clin. Oncol. 2013 (in press) - PMC - PubMed